BCL2 and breast carcinoma: Furthermore, berberine was utilized against breast cancer as it improved JNK phosphorylation, activated caspase-3, reduced the mitochondrial membrane potential, decreased the expression of Bcl-2, and increased the release of cytochrome c and AIF [261].